APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vitamin B12 Series API

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Vitamin B12 Series API Market Outlook and Growth Opportunities 2026

27 December 2025197 pages

Choose your research edition.

Industry ResearchVitamin B12 Series API Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Vitamin B12 Series API Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Vitamin B12 Series API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vitamin B12 Series API Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Vitamin B12 Series API Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Vitamin B12 Series API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Vitamin B12 Series API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Vitamin B12 Series API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vitamin B12 Series API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Vitamin B12 Series API market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Vitamin B12 Series API market include EUROAPI, Eisai Co., Ltd, HTBA, North China Pharmaceutical Company, Ningxia Kingvit Pharmaceutical, Cspc Holdings Company and Yufeng Industry Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Vitamin B12 Series API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Vitamin B12 Series API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Vitamin B12 Series API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Vitamin B12 Series API market size, projected growth trends, production technologies, key applications, and end-use industries.

Vitamin B12 Series API Segment by Company

EUROAPI

Eisai Co., Ltd

HTBA

North China Pharmaceutical Company

Ningxia Kingvit Pharmaceutical

Cspc Holdings Company

Yufeng Industry Group

Vitamin B12 Series API Segment by Type

Adenosylcobalamin

Cyanocobalamin

Hydroxocobalamin

Methylcobalamin

Vitamin B12 Series API Segment by Application

Oral Formulation

Sprays

Injectable Formulation

Vitamin B12 Series API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Vitamin B12 Series API status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Vitamin B12 Series API market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Vitamin B12 Series API significant trends, drivers, influence factors in global and regions.

6. To analyze Vitamin B12 Series API competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vitamin B12 Series API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vitamin B12 Series API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vitamin B12 Series API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Vitamin B12 Series API market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Vitamin B12 Series API industry.

Chapter 3: Detailed analysis of Vitamin B12 Series API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Vitamin B12 Series API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Vitamin B12 Series API in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Vitamin B12 Series API Industry Trends Table 2. Vitamin B12 Series API Industry Drivers Table 3. Vitamin B12 Series API Industry Opportunities and Challenges Table 4. Vitamin B12 Series API Industry Restraints Table 5. Global Vitamin B12 Series API Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Vitamin B12 Series API Revenue Share by Company (2021-2026) Table 7. Global Vitamin B12 Series API Sales Volume by Company (K G) & (2021-2026) Table 8. Global Vitamin B12 Series API Sales Volume Share by Company (2021-2026) Table 9. Global Vitamin B12 Series API Average Price (US$/K G) of Company (2021-2026) Table 10. Global Vitamin B12 Series API Company Ranking, (2024-2026) & (USD Million) Table 11. Global Vitamin B12 Series API Key Company Manufacturing Base & Headquarters Table 12. Global Vitamin B12 Series API Company, Product Type & Application Table 13. Global Vitamin B12 Series API Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Vitamin B12 Series API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Adenosylcobalamin Table 18. Significant Companies of Cyanocobalamin Table 19. Significant Companies of Hydroxocobalamin Table 20. Significant Companies of Methylcobalamin Table 21. Global Vitamin B12 Series API Sales Volume by Type 2021 VS 2025 VS 2032 (K G) Table 22. Global Vitamin B12 Series API Sales Volume by Type (2021-2026) & (K G) Table 23. Global Vitamin B12 Series API Sales Volume by Type (2027-2032) & (K G) Table 24. Global Vitamin B12 Series API Sales Volume Share by Type (2021-2026) Table 25. Global Vitamin B12 Series API Sales Volume Share by Type (2027-2032) Table 26. Global Vitamin B12 Series API Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Vitamin B12 Series API Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Vitamin B12 Series API Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Vitamin B12 Series API Sales Value Share by Type (2021-2026) Table 30. Global Vitamin B12 Series API Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Oral Formulation Table 32. Significant Companies of Sprays Table 33. Significant Companies of Injectable Formulation Table 34. Global Vitamin B12 Series API Sales Volume by Application 2021 VS 2025 VS 2032 (K G) Table 35. Global Vitamin B12 Series API Sales Volume by Application (2021-2026) & (K G) Table 36. Global Vitamin B12 Series API Sales Volume by Application (2027-2032) & (K G) Table 37. Global Vitamin B12 Series API Sales Volume Share by Application (2021-2026) Table 38. Global Vitamin B12 Series API Sales Volume Share by Application (2027-2032) Table 39. Global Vitamin B12 Series API Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Vitamin B12 Series API Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Vitamin B12 Series API Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Vitamin B12 Series API Sales Value Share by Application (2021-2026) Table 43. Global Vitamin B12 Series API Sales Value Share by Application (2027-2032) Table 44. Global Vitamin B12 Series API Sales by Region: 2021 VS 2025 VS 2032 (K G) Table 45. Global Vitamin B12 Series API Sales by Region (2021-2026) & (K G) Table 46. Global Vitamin B12 Series API Sales Market Share by Region (2021-2026) Table 47. Global Vitamin B12 Series API Sales by Region (2027-2032) & (K G) Table 48. Global Vitamin B12 Series API Sales Market Share by Region (2027-2032) Table 49. Global Vitamin B12 Series API Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Vitamin B12 Series API Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Vitamin B12 Series API Sales Value Share by Region (2021-2026) Table 52. Global Vitamin B12 Series API Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Vitamin B12 Series API Sales Value Share by Region (2027-2032) Table 54. Global Vitamin B12 Series API Market Average Price (US$/K G) by Region (2021-2026) Table 55. Global Vitamin B12 Series API Market Average Price (US$/K G) by Region (2027-2032) Table 56. Global Vitamin B12 Series API Sales by Country: 2021 VS 2025 VS 2032 (K G) Table 57. Global Vitamin B12 Series API Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Vitamin B12 Series API Sales by Country (2021-2026) & (K G) Table 59. Global Vitamin B12 Series API Sales Market Share by Country (2021-2026) Table 60. Global Vitamin B12 Series API Sales by Country (2027-2032) & (K G) Table 61. Global Vitamin B12 Series API Sales Market Share by Country (2027-2032) Table 62. Global Vitamin B12 Series API Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Vitamin B12 Series API Sales Value Market Share by Country (2021-2026) Table 64. Global Vitamin B12 Series API Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Vitamin B12 Series API Sales Value Market Share by Country (2027-2032) Table 66. EUROAPI Company Information Table 67. EUROAPI Business Overview Table 68. EUROAPI Vitamin B12 Series API Sales (K G), Value (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 69. EUROAPI Vitamin B12 Series API Product Portfolio Table 70. EUROAPI Recent Development Table 71. Eisai Co., Ltd Company Information Table 72. Eisai Co., Ltd Business Overview Table 73. Eisai Co., Ltd Vitamin B12 Series API Sales (K G), Value (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 74. Eisai Co., Ltd Vitamin B12 Series API Product Portfolio Table 75. Eisai Co., Ltd Recent Development Table 76. HTBA Company Information Table 77. HTBA Business Overview Table 78. HTBA Vitamin B12 Series API Sales (K G), Value (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 79. HTBA Vitamin B12 Series API Product Portfolio Table 80. HTBA Recent Development Table 81. North China Pharmaceutical Company Company Information Table 82. North China Pharmaceutical Company Business Overview Table 83. North China Pharmaceutical Company Vitamin B12 Series API Sales (K G), Value (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 84. North China Pharmaceutical Company Vitamin B12 Series API Product Portfolio Table 85. North China Pharmaceutical Company Recent Development Table 86. Ningxia Kingvit Pharmaceutical Company Information Table 87. Ningxia Kingvit Pharmaceutical Business Overview Table 88. Ningxia Kingvit Pharmaceutical Vitamin B12 Series API Sales (K G), Value (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 89. Ningxia Kingvit Pharmaceutical Vitamin B12 Series API Product Portfolio Table 90. Ningxia Kingvit Pharmaceutical Recent Development Table 91. Cspc Holdings Company Company Information Table 92. Cspc Holdings Company Business Overview Table 93. Cspc Holdings Company Vitamin B12 Series API Sales (K G), Value (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 94. Cspc Holdings Company Vitamin B12 Series API Product Portfolio Table 95. Cspc Holdings Company Recent Development Table 96. Yufeng Industry Group Company Information Table 97. Yufeng Industry Group Business Overview Table 98. Yufeng Industry Group Vitamin B12 Series API Sales (K G), Value (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 99. Yufeng Industry Group Vitamin B12 Series API Product Portfolio Table 100. Yufeng Industry Group Recent Development Table 101. Key Raw Materials Table 102. Raw Materials Key Suppliers Table 103. Vitamin B12 Series API Distributors List Table 104. Vitamin B12 Series API Customers List Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Vitamin B12 Series API Product Image Figure 2. Global Vitamin B12 Series API Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vitamin B12 Series API Sales Value (2021-2032) & (US$ Million) Figure 4. Global Vitamin B12 Series API Sales (2021-2032) & (K G) Figure 5. Global Vitamin B12 Series API Sales Average Price (US$/K G) & (2021-2032) Figure 6. Global Vitamin B12 Series API Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Adenosylcobalamin Image Figure 10. Cyanocobalamin Image Figure 11. Hydroxocobalamin Image Figure 12. Methylcobalamin Image Figure 13. Global Vitamin B12 Series API Sales Volume by Type (2021 VS 2025 VS 2032) & (K G) Figure 14. Global Vitamin B12 Series API Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Vitamin B12 Series API Sales Volume Share by Type (2021-2032) Figure 16. Global Vitamin B12 Series API Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Vitamin B12 Series API Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Vitamin B12 Series API Sales Value Share by Type (2021-2032) Figure 19. Oral Formulation Image Figure 20. Sprays Image Figure 21. Injectable Formulation Image Figure 22. Global Vitamin B12 Series API Sales Volume by Application (2021 VS 2025 VS 2032) & (K G) Figure 23. Global Vitamin B12 Series API Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Vitamin B12 Series API Sales Volume Share by Application (2021-2032) Figure 25. Global Vitamin B12 Series API Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Vitamin B12 Series API Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Vitamin B12 Series API Sales Value Share by Application (2021-2032) Figure 28. Global Vitamin B12 Series API Sales by Region: 2021 VS 2025 VS 2032 (K G) Figure 29. Global Vitamin B12 Series API Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Vitamin B12 Series API Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Vitamin B12 Series API Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Vitamin B12 Series API Sales Value (2021-2032) & (US$ Million) Figure 33. North America Vitamin B12 Series API Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Vitamin B12 Series API Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Vitamin B12 Series API Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Vitamin B12 Series API Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Vitamin B12 Series API Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Vitamin B12 Series API Sales Value (2021-2032) & (US$ Million) Figure 39. South America Vitamin B12 Series API Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Vitamin B12 Series API Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Vitamin B12 Series API Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Vitamin B12 Series API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Vitamin B12 Series API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Vitamin B12 Series API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Vitamin B12 Series API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Vitamin B12 Series API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Vitamin B12 Series API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Vitamin B12 Series API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Vitamin B12 Series API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Vitamin B12 Series API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Vitamin B12 Series API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Vitamin B12 Series API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Vitamin B12 Series API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Vitamin B12 Series API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Vitamin B12 Series API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Vitamin B12 Series API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Vitamin B12 Series API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Vitamin B12 Series API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Vitamin B12 Series API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Vitamin B12 Series API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Vitamin B12 Series API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Vitamin B12 Series API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Vitamin B12 Series API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Vitamin B12 Series API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Vitamin B12 Series API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Vitamin B12 Series API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Vitamin B12 Series API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Vitamin B12 Series API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Vitamin B12 Series API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Vitamin B12 Series API Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Vitamin B12 Series API Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Adenosylcobalamin
  • Cyanocobalamin
  • Hydroxocobalamin
  • Methylcobalamin
Applications
  • Oral Formulation
  • Sprays
  • Injectable Formulation
Companies covered
  • EUROAPI
  • Eisai Co., Ltd
  • HTBA
  • North China Pharmaceutical Company
  • Ningxia Kingvit Pharmaceutical
  • Cspc Holdings Company
  • Yufeng Industry Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Vitamin B12 Series API Sales Value (2021-2032)
  4. 1.2.2 Global Vitamin B12 Series API Sales Volume (2021-2032)
  5. 1.2.3 Global Vitamin B12 Series API Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Vitamin B12 Series API Market Dynamics
  1. 2.1 Vitamin B12 Series API Industry Trends
  2. 2.2 Vitamin B12 Series API Industry Drivers
  3. 2.3 Vitamin B12 Series API Industry Opportunities and Challenges
  4. 2.4 Vitamin B12 Series API Industry Restraints
3 Vitamin B12 Series API Market by Company
  1. 3.1 Global Vitamin B12 Series API Company Revenue Ranking in 2025
  2. 3.2 Global Vitamin B12 Series API Revenue by Company (2021-2026)
  3. 3.3 Global Vitamin B12 Series API Sales Volume by Company (2021-2026)
  4. 3.4 Global Vitamin B12 Series API Average Price by Company (2021-2026)
  5. 3.5 Global Vitamin B12 Series API Company Ranking (2024-2026)
  6. 3.6 Global Vitamin B12 Series API Company Manufacturing Base and Headquarters
  7. 3.7 Global Vitamin B12 Series API Company Product Type and Application
  8. 3.8 Global Vitamin B12 Series API Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Vitamin B12 Series API Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Vitamin B12 Series API Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Vitamin B12 Series API Market by Type
  1. 4.1 Vitamin B12 Series API Type Introduction
  2. 4.1.1 Adenosylcobalamin
  3. 4.1.2 Cyanocobalamin
  4. 4.1.3 Hydroxocobalamin
  5. 4.1.4 Methylcobalamin
  6. 4.2 Global Vitamin B12 Series API Sales Volume by Type
  7. 4.2.1 Global Vitamin B12 Series API Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Vitamin B12 Series API Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Vitamin B12 Series API Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Vitamin B12 Series API Sales Value by Type
  11. 4.3.1 Global Vitamin B12 Series API Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Vitamin B12 Series API Sales Value by Type (2021-2032)
  13. 4.3.3 Global Vitamin B12 Series API Sales Value Share by Type (2021-2032)
5 Vitamin B12 Series API Market by Application
  1. 5.1 Vitamin B12 Series API Application Introduction
  2. 5.1.1 Oral Formulation
  3. 5.1.2 Sprays
  4. 5.1.3 Injectable Formulation
  5. 5.2 Global Vitamin B12 Series API Sales Volume by Application
  6. 5.2.1 Global Vitamin B12 Series API Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Vitamin B12 Series API Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Vitamin B12 Series API Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Vitamin B12 Series API Sales Value by Application
  10. 5.3.1 Global Vitamin B12 Series API Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Vitamin B12 Series API Sales Value by Application (2021-2032)
  12. 5.3.3 Global Vitamin B12 Series API Sales Value Share by Application (2021-2032)
6 Vitamin B12 Series API Regional Sales and Value Analysis
  1. 6.1 Global Vitamin B12 Series API Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Vitamin B12 Series API Sales by Region (2021-2032)
  3. 6.2.1 Global Vitamin B12 Series API Sales by Region: 2021-2026
  4. 6.2.2 Global Vitamin B12 Series API Sales by Region (2027-2032)
  5. 6.3 Global Vitamin B12 Series API Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Vitamin B12 Series API Sales Value by Region (2021-2032)
  7. 6.4.1 Global Vitamin B12 Series API Sales Value by Region: 2021-2026
  8. 6.4.2 Global Vitamin B12 Series API Sales Value by Region (2027-2032)
  9. 6.5 Global Vitamin B12 Series API Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Vitamin B12 Series API Sales Value (2021-2032)
  12. 6.6.2 North America Vitamin B12 Series API Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Vitamin B12 Series API Sales Value (2021-2032)
  15. 6.7.2 Europe Vitamin B12 Series API Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Vitamin B12 Series API Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Vitamin B12 Series API Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Vitamin B12 Series API Sales Value (2021-2032)
  21. 6.9.2 South America Vitamin B12 Series API Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Vitamin B12 Series API Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Vitamin B12 Series API Sales Value Share by Country, 2025 VS 2032
7 Vitamin B12 Series API Country-level Sales and Value Analysis
  1. 7.1 Global Vitamin B12 Series API Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Vitamin B12 Series API Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Vitamin B12 Series API Sales by Country (2021-2032)
  4. 7.3.1 Global Vitamin B12 Series API Sales by Country (2021-2026)
  5. 7.3.2 Global Vitamin B12 Series API Sales by Country (2027-2032)
  6. 7.4 Global Vitamin B12 Series API Sales Value by Country (2021-2032)
  7. 7.4.1 Global Vitamin B12 Series API Sales Value by Country (2021-2026)
  8. 7.4.2 Global Vitamin B12 Series API Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Vitamin B12 Series API Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Vitamin B12 Series API Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Vitamin B12 Series API Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Vitamin B12 Series API Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Vitamin B12 Series API Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Vitamin B12 Series API Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Vitamin B12 Series API Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Vitamin B12 Series API Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Vitamin B12 Series API Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Vitamin B12 Series API Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Vitamin B12 Series API Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Vitamin B12 Series API Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Vitamin B12 Series API Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Vitamin B12 Series API Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Vitamin B12 Series API Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Vitamin B12 Series API Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Vitamin B12 Series API Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Vitamin B12 Series API Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Vitamin B12 Series API Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Vitamin B12 Series API Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Vitamin B12 Series API Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Vitamin B12 Series API Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Vitamin B12 Series API Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Vitamin B12 Series API Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Vitamin B12 Series API Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Vitamin B12 Series API Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Vitamin B12 Series API Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Vitamin B12 Series API Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Vitamin B12 Series API Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Vitamin B12 Series API Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 EUROAPI
  2. 8.1.1 EUROAPI Company Information
  3. 8.1.2 EUROAPI Business Overview
  4. 8.1.3 EUROAPI Vitamin B12 Series API Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 EUROAPI Vitamin B12 Series API Product Portfolio
  6. 8.1.5 EUROAPI Recent Developments
  7. 8.2 Eisai Co., Ltd
  8. 8.2.1 Eisai Co., Ltd Company Information
  9. 8.2.2 Eisai Co., Ltd Business Overview
  10. 8.2.3 Eisai Co., Ltd Vitamin B12 Series API Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Eisai Co., Ltd Vitamin B12 Series API Product Portfolio
  12. 8.2.5 Eisai Co., Ltd Recent Developments
  13. 8.3 HTBA
  14. 8.3.1 HTBA Company Information
  15. 8.3.2 HTBA Business Overview
  16. 8.3.3 HTBA Vitamin B12 Series API Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 HTBA Vitamin B12 Series API Product Portfolio
  18. 8.3.5 HTBA Recent Developments
  19. 8.4 North China Pharmaceutical Company
  20. 8.4.1 North China Pharmaceutical Company Company Information
  21. 8.4.2 North China Pharmaceutical Company Business Overview
  22. 8.4.3 North China Pharmaceutical Company Vitamin B12 Series API Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 North China Pharmaceutical Company Vitamin B12 Series API Product Portfolio
  24. 8.4.5 North China Pharmaceutical Company Recent Developments
  25. 8.5 Ningxia Kingvit Pharmaceutical
  26. 8.5.1 Ningxia Kingvit Pharmaceutical Company Information
  27. 8.5.2 Ningxia Kingvit Pharmaceutical Business Overview
  28. 8.5.3 Ningxia Kingvit Pharmaceutical Vitamin B12 Series API Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Ningxia Kingvit Pharmaceutical Vitamin B12 Series API Product Portfolio
  30. 8.5.5 Ningxia Kingvit Pharmaceutical Recent Developments
  31. 8.6 Cspc Holdings Company
  32. 8.6.1 Cspc Holdings Company Company Information
  33. 8.6.2 Cspc Holdings Company Business Overview
  34. 8.6.3 Cspc Holdings Company Vitamin B12 Series API Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Cspc Holdings Company Vitamin B12 Series API Product Portfolio
  36. 8.6.5 Cspc Holdings Company Recent Developments
  37. 8.7 Yufeng Industry Group
  38. 8.7.1 Yufeng Industry Group Company Information
  39. 8.7.2 Yufeng Industry Group Business Overview
  40. 8.7.3 Yufeng Industry Group Vitamin B12 Series API Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Yufeng Industry Group Vitamin B12 Series API Product Portfolio
  42. 8.7.5 Yufeng Industry Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Vitamin B12 Series API Value Chain Analysis
  2. 9.1.1 Vitamin B12 Series API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Vitamin B12 Series API Sales Mode & Process
  6. 9.2 Vitamin B12 Series API Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Vitamin B12 Series API Distributors
  9. 9.2.3 Vitamin B12 Series API Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst